[go: up one dir, main page]

FR3125704B1 - Combination product to relieve symptoms of sore throats - Google Patents

Combination product to relieve symptoms of sore throats Download PDF

Info

Publication number
FR3125704B1
FR3125704B1 FR2108267A FR2108267A FR3125704B1 FR 3125704 B1 FR3125704 B1 FR 3125704B1 FR 2108267 A FR2108267 A FR 2108267A FR 2108267 A FR2108267 A FR 2108267A FR 3125704 B1 FR3125704 B1 FR 3125704B1
Authority
FR
France
Prior art keywords
combination product
sore throats
relieve symptoms
throats
sore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2108267A
Other languages
French (fr)
Other versions
FR3125704A1 (en
Inventor
Amandine Bart
Eugénie Bertrand
Marilyn Gentilhomme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Urgo Recherche Innovation et Developpement
Original Assignee
Urgo Recherche Innovation et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation et Developpement filed Critical Urgo Recherche Innovation et Developpement
Priority to FR2108267A priority Critical patent/FR3125704B1/en
Priority to PCT/EP2022/071120 priority patent/WO2023006837A1/en
Publication of FR3125704A1 publication Critical patent/FR3125704A1/en
Application granted granted Critical
Publication of FR3125704B1 publication Critical patent/FR3125704B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins du miel, de l’eucalyptus et de la guimauve pour aider à soulager les symptômes des maux de gorges. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour le traitement des maux de gorges.The present invention relates to a combination product comprising, as active substances, at least honey, eucalyptus and marshmallow to help relieve the symptoms of sore throats. The invention finally relates to the use of a combination product as previously defined for the treatment of sore throats.

FR2108267A 2021-07-29 2021-07-29 Combination product to relieve symptoms of sore throats Active FR3125704B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2108267A FR3125704B1 (en) 2021-07-29 2021-07-29 Combination product to relieve symptoms of sore throats
PCT/EP2022/071120 WO2023006837A1 (en) 2021-07-29 2022-07-27 Combination product comprising marshmallow, eucalyptus and honey to alleviate the symptoms of sore throats

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2108267A FR3125704B1 (en) 2021-07-29 2021-07-29 Combination product to relieve symptoms of sore throats
FR2108267 2021-07-29

Publications (2)

Publication Number Publication Date
FR3125704A1 FR3125704A1 (en) 2023-02-03
FR3125704B1 true FR3125704B1 (en) 2025-01-10

Family

ID=77411973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2108267A Active FR3125704B1 (en) 2021-07-29 2021-07-29 Combination product to relieve symptoms of sore throats

Country Status (2)

Country Link
FR (1) FR3125704B1 (en)
WO (1) WO2023006837A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016004395A1 (en) * 2014-07-02 2016-01-07 Xlear, Inc Sore-throat compositions and related methods

Also Published As

Publication number Publication date
FR3125704A1 (en) 2023-02-03
WO2023006837A1 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
Zhong et al. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
MA27997A1 (en) COMPOUNDS AND COMPOSITIONS INHIBITING TYROSINE KINASE RECEPTOR ACTIVITY
DK0429189T3 (en) Use of sertraline in the manufacture of a drug for the treatment of obsessive-compulsive disorders
FI961438A7 (en) beta-amyloid protein production inhibitors
Kangasniemi et al. Classic migraine: effective prophylaxis with metoprolol
ES2166111T3 (en) USE OF TIAGABINE FOR THE TREATMENT OF SLEEP DISORDERS.
DE69400435D1 (en) USE OF CARBAMAZEPINE AND OXCARBAZEPINE FOR THE TREATMENT OF PARKINSON AND THE PARKINSON SYNDROME
CY1106845T1 (en) USE OF FLUMAZENIL FOR THE PREPARATION OF A DRUG FOR THE TREATMENT OF COCAINE DEPENDENCE
PE11399A1 (en) COMBINATION OF LORATADINE AND A DECONESCENTANT FOR THE TREATMENT OF ASTHMA
FR3125704B1 (en) Combination product to relieve symptoms of sore throats
ATE280578T1 (en) COMBINATION OF A RETINOIC ACID METABOLISM BLOCKING DRUG AND A TOCOPHEROL
CO4940448A1 (en) GLASS MODIFICATION OF A MEDICINAL SUBSTANCE
FR3127690B1 (en) Combination product to relieve sore throats
Croxtall Clonidine extended-release: in attention-deficit hyperactivity disorder
FR3097744B1 (en) Combination product to help maintain the body's natural defenses
EP0305277A3 (en) Use of 2-amino-6-trifluoromethoxybenzothiazole for the preparation of a medicament for the treatment of sleep disorders and depression
MA27539A1 (en) NEW SYNERGISTIC COMBINATION CONTAINING ROFLUMILAST AND FORMOTEROL
ATE16565T1 (en) PHARMACEUTICAL ORAL DOSAGE FORMS OF AN ACTIVE SUBSTANCE CAPABLE OF GENERATING OR RELEASING BICARBONATION.
MA26698A1 (en) LIQUID CONCENTRATED PHARMACEUTICAL COMPOSITION OF SERTRALINE AND PROCESS FOR ITS PREPARATION
FR3084834B1 (en) NASAL INHALER FOR RESPIRATORY WELL-BEING
FR3099698B1 (en) Combination product to help maintain the body's natural defenses and get back in shape
MA27150A1 (en) PHARMACEUTICAL COMBINATIONS OF AN A2A ADENOSINE RECEPTOR AGONIST AND A BETA-2 ADRENERGIC RECEPTOR AGONIST
FR3101540B1 (en) Combination product to relieve the bronchial tubes and facilitate falling asleep
Masilamani et al. Escitalopram (Lexapro) for depression
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230203

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5